Answers are grounded in this paper and cite their sources.
Fisetin has potential anti-ageing activity, but its effects on human gingival fibroblast (HGF) senescence remain unclear. This study investigated fisetin using network pharmacology, molecular docking, and in vitro assays. Network analysis predicted fisetin-related targets enriched in cellular senescence, PI3K-Akt signalling, extracellular matrix remodelling, and inflammation pathways, with TP53, AKT1, and matrix metalloproteinases as potential key nodes. Docking suggested favourable binding of fisetin to core targets, particularly TP53. In tert-butyl hydroperoxide-induced HGFs, fisetin improved migration, reduced senescence-associated beta-galactosidase positivity, and decreased p53 and p21 protein expression. Fisetin also reduced MMP1 and MMP9 mRNA levels while restoring COL1A1 and COL3A1 mRNA expression. In a separate lipopolysaccharide-stimulated inflammation model, fisetin reduced interleukin-6 secretion. These findings suggest that fisetin attenuates selected senescence-associated phenotypes in HGFs, accompanied by reduced p53/p21 expression and improved extracellular matrix-related marker profiles, warranting further validation in tissue-level, animal, and clinical studies in future work, although causal mediation was not established.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: